Dapagliflozin Post Marketing Surveillance in HF and CKD

Clinical trial NCT05134701 · COMPLETED

Trial details

NCT number: NCT05134701
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Heart Failure Chronic Kidney Disease

Start date: 2022-03-10
Primary completion: 2024-05-20
Enrollment: 815

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.